[Hyperinsulinemia as a consequence of systemic venous drainage in patients with pancreas transplantation].
To evaluate the metabolic consequences of pancreatic transplantation with systemic venous drainage on beta cell function, we examined insulin and C-peptide responses to arginine and secretin in type I diabetic recipients of pancreas transplantation (n = 16), and normal controls (n = 28). Basal insulin levels were 24 +/- 3 microU/l in pancreas recipients, and 7 +/- 1 microU/l in controls (p less than 0.001). Stimulated insulin levels following arginine (MANOVA, p less than 0.001), and secretin (MANOVA, p less than 0.001) were 1.5 to 3 fold elevated compared to controls. In contrast, integrated C-peptide responses following stimulation with arginine or secretin did not differ significantly between the two groups. We conclude that recipients of pancreas allografts with systemic venous drainage have elevated basal and stimulated insulin levels and that these alterations are primarily due to alterations of first pass hepatic insulin clearance although insulin resistance secondary to immunosuppressive therapy (including prednisone) may also play a contributing role. To avoid hyperinsulinemia and its possible long term adverse consequences, transplantation of pancreas allografts in sites with portal rather than systemic venous drainage may be preferable.
Diem
P
P
Diabetes-Station, Medizinische Universitätsklinik, Inselspital Bern.
Abid
M
M
Redmon
J B
JB
Sutherland
D E
DE
Robertson
R P
RP
D000328:Adult; D001120:Arginine; D002096:C-Peptide / Q000097:blood; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D008297:Male; D010179:Pancreas / Q000098:blood supply; D016035:Pancreas Transplantation; D012633:Secretin; D016042:Transplantation, Heterotopic; D014680:Veins
D002096:C-Peptide; D007328:Insulin; D012633:Secretin; D001120:Arginine
Hyperinsulinämie als Folge der systemischen venösen Drainage bei Patienten mit Pankreastransplantation.